GSK · Pharma and healthcare · one day
GSK (GSK): news on Wednesday 11 November 2026
News from the 24 hours to Wednesday morning, 11 November 2026.
Tone of the day
+4.5positive
+4.5
Relevant headlines6
Stories6
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
What drove it
- Access to Medicine ranking
- share price and dividend appeal
- pipeline focus at UBS conference
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Thu 5 Nov | +5.0 | 11 |
| Fri 6 Nov | +4.5 | 8 |
| Sat 7 Nov | +4.5 | 17 |
| Sun 8 Nov | +5.7 | 2 |
| Mon 9 Nov | −3.3 | 3 |
| Tue 10 Nov | +6.3 | 13 |
| Wed 11 Nov | +4.5 | 6 |
| Thu 12 Nov | +4.5 | 12 |
| Fri 13 Nov | +4.2 | 14 |
6 stories · 6 headlines · strongest first
Pharma and healthcare on 11 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| GSK takes second place in the Access to Medicine Index 2026 +9.21 headline today · GSK announces its second-place ranking in the index. | ||
| +9.2 | High placing in access-to-medicine ranking boosts reputation. | |
| Tesco, GSK and Diageo among three UK dividend picks for defensive income +5.01 headline today · A screening piece lists GSK among defensive UK dividend stocks. | ||
| +5.0 | Listed among defensive income picks, though one of several stocks. | |
| GSK share price at 1,917p on 10 November +2.51 headline today · A price report gives GSK shares at 1,917.0p, up 0.66%. | ||
| +2.5 | Modest daily share price gain reported.} | |
| GSK has two investor conferences coming up +2.71 headline today · 7 in all, since 9 November · A piece says GSK heads into the UBS conference with its pipeline in focus. | ||
| +2.0 | Investor attention on pipeline ahead of a conference. | |
| Vincent Fantauzzo and GSK hold a life-drawing class +1.71 headline today · GSK and artist Vincent Fantauzzo host a life-drawing class. | ||
| +1.7 | Awareness campaign with an artist; minor reputational positive. | |
| Moderna and GSK resolve dispute over vaccine patents +5.71 headline today · 11 in all, since 7 November · A piece mentions the GSK truce with Moderna ahead of 12 November. | ||
| +1.7 | Preview mentioning a settlement and R&D focus; mixed and brief. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated GSK: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.